Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-09-13

Clinical Trial Update: Evaluation of Weekly Tafenoquine [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating weekly tafenoquine for malaria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Malaria | Phase 2 | Status: COMPLETED